Literature DB >> 20410346

Impact of remote versus local sampling on sensitivity of genotypic antiretroviral resistance testing.

Maddalena Balestrieri, Antonella Marconi, Genny Meini, Andrea Rosi, Francesco Saladini, Ilaria Vicenti, Francesca Razzolini, Maurizio Zazzi.   

Abstract

Mesh:

Year:  2010        PMID: 20410346      PMCID: PMC2884515          DOI: 10.1128/JCM.02394-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors.

Authors:  C Peduzzi; P Pierotti; G Venturi; L Romano; F Mazzotta; M Zazzi
Journal:  J Clin Virol       Date:  2002-07       Impact factor: 3.168

2.  Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.

Authors:  Chris Verhofstede; Filip Van Wanzeele; Bea Van Der Gucht; Jolanda Pelgrom; Linos Vandekerckhove; Jean Plum; Dirk Vogelaers
Journal:  J Med Virol       Date:  2007-09       Impact factor: 2.327

3.  Genotypic antiretroviral drug resistance testing at low viral loads in the UK.

Authors:  P A Cane; S Kaye; E Smit; P Tilston; S Kirk; J Shepherd; M Hopkins; H Zhang; A M Geretti
Journal:  HIV Med       Date:  2008-06-28       Impact factor: 3.180

4.  Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.

Authors:  Soo Aleman; Karin Söderbärg; Ubaldo Visco-Comandini; Gisela Sitbon; Anders Sönnerborg
Journal:  AIDS       Date:  2002-05-03       Impact factor: 4.177

5.  Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Authors:  Martin S Hirsch; Huldrych F Günthard; Jonathan M Schapiro; Françoise Brun-Vézinet; Bonaventura Clotet; Scott M Hammer; Victoria A Johnson; Daniel R Kuritzkes; John W Mellors; Deenan Pillay; Patrick G Yeni; Donna M Jacobsen; Douglas D Richman
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.